Rosenblat, T. L., McDevitt, M. R., Carrasquillo, J. A., Pandit-Taskar, N., Frattini, M. G., Maslak, P. G., Park, J. H., Douer, D., Cicic, D., Larson, S. M., Scheinberg, D. A., & Jurcic, J. G. (2022). Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab. Clinical Cancer Research, 28(10), 2030–2037. https://doi.org/10.1158/1078-0432.ccr-21-3712
Subjects:
Immunoconjugates
(MeSH)
Leukemia, Myeloid, Acute
(MeSH)
Development and Applications of Radiopharmaceuticals
(OpenAlex Topic)
Neuroblastoma Research and Treatment
(OpenAlex Topic)
Diagnosis and Treatment of Prosthetic Joint Infections
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1158/1078-0432.CCR-21-3712
PMID:
Journal:
Publication Date:
Data Source:
Scopus